News

Researchers have discovered which dog breeds are more likely to get cancer, and the results disprove the notion that large dogs have a higher risk of the disease.
People with locally advanced head and neck squamous cell carcinoma (HNSCC) now have a new treatment option that could extend their lives with fewer side effects. The U.S. Food and Drug Administration ...
Neo-adjuvant nivolumab or nivolumab with ipilimumab in advanced cutaneous squamous cell carcinoma prior to surgery. ClinicalTrials.gov. Updated October 26, 2022.
The receptor for the complement component C5a may be a useful therapeutic target for cases of cutaneous squamous cell carcinoma (cSCC), according to a new report. 1 The study, published in the ...
Traws Pharma published key clinical efficacy data for rigosertib in patients with RDEB-associated squamous cell carcinoma. What is rigosertib being evaluated for?
Regeneron Pharmaceuticals announced promising results from the Phase 3 C-POST trial of Libtayo (cemiplimab), a PD-1 inhibitor for patients with high-risk cutaneous squamous cell carcinoma (CSCC ...
Survival for head and neck squamous cell carcinoma treated with versus without neoadjuvant systemic therapy: A national propensity score–matched analysis.. If you have the appropriate software ...
A patient shares his experience with a squamous cell carcinoma diagnosis, treatment and recovery.
Mohs surgery significantly improved recurrence, metastasis, and mortality rates in patients with primary high-stage cutaneous cell carcinoma in a retrospective cohort study of 216 patients treated ...
Leonard-Neverov, of Phoenix, Arizona, told Newsweek: "Remington's official diagnosis was papillary squamous cell carcinoma, a type of cancer that affects the mouth.
“Oral squamous cell carcinoma is the second-most common malignant oral tumor in dogs, and this papillary subtype has previously been reported in young dogs.” ...